The CMD αBET™ system is a fully integrated testing system that provides a more rapid and sustainable solution to endotoxin testing without compromising sensitivity or performance. Using a fraction of FDA-licensed turbidimetric Limulus amoebocyte lysate (LAL) reagent, quantitative results are provided in under half the time of other testing formats, with minimal user input. The onboard FDA part 11 ready software package ensures data integrity and walks users through performing a pharmacopeial-compliant assay or allows flexible sample analysis. The αBET™ system is designed for in-process or final-product testing in pharmaceutical manufacturing, quality control, and research and development.

Like other turbidimetric assays, αBET^® measures changes in the transmission of light passing through a sample to monitor the progress of the reaction. However, the method used to deliver and detect the light in the αBET™ system confers advantages not only in terms of sensitivity and speed but also allowing for a wider range of sample matrices to be analyzed when compared to traditional turbidimetric/chromogenic assays, which typically struggle with coloured or hazy samples.

The instrument employs a 4-channel consumable to perform four simultaneous tests with run times of between ~3 minutes for a 10 EU/mL sample and ~30 minutes for samples containing 0.001 EU/mL. The fully flexible system allows users to choose calibration ranges without having to pre-select consumables/reagents with specific sensitivities.

Head over to www.cm-dx.com/alphabet to find out how the αBET™ system can meet your endotoxin testing needs or use the Request Information button below to email the supplier directly.